| A novel truncating variant in FLNC-encoded filamin C may serve as a proarrhythmic genetic substrate for arrhythmogenic bileaflet mitral valve prolapse syndrome S Bains, DJ Tester, SJ Asirvatham, PA Noseworthy, MJ Ackerman, ... Mayo Clinic Proceedings 94 (5), 906-913, 2019 | 61 | 2019 |
| Phenotypes of overdiagnosed long QT syndrome S Bains, R Neves, JM Bos, JR Giudicessi, C MacIntyre, MJ Ackerman Journal of the American College of Cardiology 81 (5), 477-486, 2023 | 12 | 2023 |
| A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome S Bains, SM Dotzler, C Krijger, JR Giudicessi, D Ye, H Bikker, RK Rohatgi, ... Heart Rhythm 19 (3), 435-442, 2022 | 12 | 2022 |
| Suppression and Replacement Gene Therapy for KCNH2-Mediated Arrhythmias S Bains, W Zhou, SM Dotzler, K Martinez, CSJ Kim, DJ Tester, D Ye, ... Circulation: Genomic and Precision Medicine 15 (6), e003719, 2022 | 11 | 2022 |
| Spectrum and prevalence of side effects and complications with guideline-directed therapies for congenital long QT syndrome K Martinez, S Bains, JR Giudicessi, JM Bos, R Neves, MJ Ackerman Heart rhythm 19 (10), 1666-1672, 2022 | 8 | 2022 |
| Precision therapy in congenital long QT syndrome R Neves, S Bains, JM Bos, C MacIntyre, JR Giudicessi, MJ Ackerman Trends in cardiovascular medicine 34 (1), 39-47, 2024 | 6 | 2024 |
| Sudden cardiac arrest occurring in temporal proximity to consumption of energy drinks KA Martinez, S Bains, R Neves, JR Giudicessi, JM Bos, MJ Ackerman Heart Rhythm, 2024 | 4 | 2024 |
| Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome S Bains, A Lador, R Neves, JM Bos, JR Giudicessi, BC Cannon, ... Heart rhythm 19 (1), 81-87, 2022 | 3 | 2022 |
| Fatal cardiac arrhythmias during electronic gaming in patients with genetically mediated heart diseases R Neves, S Bains, JM Bos, CJ MacIntyre, JR Giudicessi, MJ Ackerman Journal of the American College of Cardiology 82 (7), 603-611, 2023 | 2 | 2023 |
| State of Gene Therapy for Monogenic Cardiovascular Diseases S Bains, JR Giudicessi, KE Odening, MJ Ackerman Mayo Clinic Proceedings 99 (4), 610-629, 2024 | 1 | 2024 |
| Injectable contraceptive Depo-Provera induces erratic beating patterns in patient-specific induced pluripotent stem cell–derived cardiomyocytes with long QT syndrome type 2 AM Pinsky, X Gao, S Bains, CJ Kim, J Louradour, KE Odening, DJ Tester, ... Heart rhythm 20 (6), 910-917, 2023 | 1 | 2023 |
| PO-01-134 AN INTERNATIONAL MULTICENTER COHORT STUDY ON BETA-BLOCKER FREE TREATMENT STRATEGIES FOR CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA RA Neves, S Bains, JM Bos, C van der Werf, A Bergeman, P Peltenburg, ... Heart Rhythm 20 (5), S169-S170, 2023 | 1 | 2023 |
| Elucidation of ALG10B as a Novel Long-QT Syndrome–Susceptibility Gene W Zhou, D Ye, DJ Tester, S Bains, JR Giudicessi, CM Haglund-Turnquist, ... Circulation: Genomic and Precision Medicine 16 (2), e003726, 2023 | 1 | 2023 |
| PO-704-02 Vaping-associated sudden death in the young S Bains, R Garmany, X Gao, RAL Neves, JM Bos, D Tester, JR Giudicessi, ... Heart Rhythm 19 (5), S450, 2022 | 1 | 2022 |
| PRECISION THERAPY IN CONGENITAL LONG QT SYNDROME S Bains, R Neves, JM Bos, J Giudicessi, MJ Ackerman Journal of the American College of Cardiology 79 (9_Supplement), 1375-1375, 2022 | 1 | 2022 |
| B-PO04-169 ROLE OF CHRONIC, LONG TERM INTRAVENOUS LIDOCAINE IN THE CLINICAL MANAGEMENT OF PATIENTS WITH MALIGNANT TYPE 3 LONG QT SYNDROME S Bains, A Lador, JM Bos, MJ Ackerman Heart Rhythm 18 (8), S347, 2021 | 1 | 2021 |
| KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome S Bains, L Giammarino, S Nimani, N Alerni, DJ Tester, CSJ Kim, ... European heart journal, ehae476, 2024 | | 2024 |
| In vivo KCNH2-suppression-replacement gene therapy attenuates the pathogenic phenotype in transgenic rabbits with short QT syndrome type 1 S Nimani, S Bains, N Alerni, L Giammarino, J Louradour, A Horvath, ... Europace 26 (Supplement_1), euae102. 630, 2024 | | 2024 |
| In vivo KCNQ1-suppression-replacement gene therapy in transgenic LQT1 rabbits restores a physiological QT interval at baseline and under catecholamine infusion L Giammarino, S Bains, J Louradour, S Nimani, N Alerni, D Tester, ... Europace 26 (Supplement_1), euae102. 605, 2024 | | 2024 |
| PO-02-090 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY FOR CHANNELOPATHIES: A SINGLE CENTER EXPERIENCE RA Neves, S Bains, JM Bos, JR Giudicessi, MJ Ackerman Heart Rhythm 21 (5), S298, 2024 | | 2024 |
